Curis Lifesciences (NSE:CURIS) PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
23 GF Score
Price ₹200.05
! 3 Warning Signs
View Full Analysis

What is Curis Lifesciences PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Curis Lifesciences's share price is ₹200.05. Curis Lifesciences does not have enough years/quarters to calculate the Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024. Therefore GuruFocus does not calculate PS Ratio at this moment.

The historical rank and industry rank for Curis Lifesciences's PS Ratio or its related term are showing as below:

NSE:CURIS' s PS Ratio Range Over the Past 10 Years
Min: 0.28   Med: 0.44   Max: 2.38
Current: 0.62

During the past 5 years, Curis Lifesciences's highest PS Ratio was 2.38. The lowest was 0.28. And the median was 0.44.

NSE:CURIS's PS Ratio is ranked better than
84.7% of 954 companies
in the Drug Manufacturers industry
Industry Median: 2.335 vs NSE:CURIS: 0.62

Curis Lifesciences's Revenue per Sharefor the three months ended in Jun. 2024 was ₹11.14.

During the past 12 months, the average Revenue per Share Growth Rate of Curis Lifesciences was 449.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 94.90% per year.

During the past 5 years, Curis Lifesciences's highest 3-Year average Revenue per Share Growth Rate was 94.90% per year. The lowest was 94.90% per year. And the median was 94.90% per year.

Back to Basics: PS Ratio


Curis Lifesciences  (NSE:CURIS) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Curis Lifesciences PS Ratio Related Terms


Curis Lifesciences PS Ratio Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences PS Ratio Chart

Curis Lifesciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
PS Ratio
- - - - 1.24

Curis Lifesciences Quarterly Data
Jun24
PS Ratio -

NSE:CURIS vs ZTS: PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curis Lifesciences PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's PS Ratio distribution charts can be found below:

* The bar in red indicates where Curis Lifesciences's PS Ratio falls into.


NSE:CURIS
23GF Score
Curis Lifesciences Ltd NSE:CURIS
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Curis Lifesciences's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=200.05/
=

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
23GF Score

Get the complete analysis for NSE:CURIS

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹200.05
Price